Causeway Capital Management LLC Sells 191,358 Shares of Genpact Limited $G

Key Points

• Causeway Capital Management LLC reduced its holdings in Genpact Limited by 16.8%, selling 191,358 shares during the first quarter.
• Genpact's latest earnings report showcased $0.88 earnings per share, exceeding estimates and indicating a year-over-year revenue growth of 6.6%.
• The company has announced a quarterly dividend of $0.17 per share, reflecting a dividend yield of 1.5% and a payout ratio of 22.59%.

Causeway Capital Management LLC decreased its position in Genpact Limited (NYSE:G - Free Report) by 16.8% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 944,660 shares of the business services provider's stock after selling 191,358 shares during the quarter. Genpact makes up approximately 1.0% of Causeway Capital Management LLC's portfolio, making the stock its 27th largest position. Causeway Capital Management LLC owned about 0.54% of Genpact worth $47,592,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. Envestnet Portfolio Solutions Inc. boosted its holdings in Genpact by 59.2% during the first quarter. Envestnet Portfolio Solutions Inc. now owns 10,355 shares of the business services provider's stock worth $522,000 after purchasing an additional 3,849 shares during the last quarter. Wealth Enhancement Advisory Services LLC raised its stake in Genpact by 20.6% in the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 9,650 shares of the business services provider's stock valued at $486,000 after acquiring an additional 1,651 shares during the period. GAMMA Investing LLC increased its stake in shares of Genpact by 88.0% in the first quarter. GAMMA Investing LLC now owns 9,744 shares of the business services provider's stock worth $491,000 after purchasing an additional 4,561 shares in the last quarter. 111 Capital bought a new position in Genpact in the 4th quarter worth approximately $301,000. Finally, Assenagon Asset Management S.A. purchased a new stake in shares of Genpact during the first quarter worth $2,396,000. Hedge funds and other institutional investors own 96.03% of the company's stock.

Genpact Price Performance

Shares of Genpact stock opened at $45.4240 on Tuesday. The stock has a market capitalization of $7.92 billion, a P/E ratio of 15.09, a price-to-earnings-growth ratio of 1.56 and a beta of 0.92. Genpact Limited has a one year low of $37.82 and a one year high of $56.76. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.53 and a quick ratio of 1.53. The business's 50 day simple moving average is $44.09 and its two-hundred day simple moving average is $46.76.

Genpact (NYSE:G - Get Free Report) last issued its earnings results on Thursday, August 7th. The business services provider reported $0.88 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.85 by $0.03. Genpact had a net margin of 10.92% and a return on equity of 22.15%. The firm had revenue of $1.25 billion for the quarter, compared to analysts' expectations of $1.23 billion. During the same quarter last year, the business earned $0.79 earnings per share. The business's revenue was up 6.6% on a year-over-year basis. Genpact has set its FY 2025 guidance at 3.510-3.580 EPS. Q3 2025 guidance at 0.890-0.900 EPS. Analysts forecast that Genpact Limited will post 3.21 EPS for the current year.

Genpact Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, September 25th. Stockholders of record on Thursday, September 11th will be paid a dividend of $0.17 per share. This represents a $0.68 annualized dividend and a dividend yield of 1.5%. The ex-dividend date of this dividend is Thursday, September 11th. Genpact's dividend payout ratio is 22.59%.

Analyst Upgrades and Downgrades

A number of research firms have weighed in on G. Mizuho lifted their target price on Genpact from $48.00 to $51.00 and gave the company a "neutral" rating in a report on Tuesday, July 1st. Deutsche Bank Aktiengesellschaft initiated coverage on Genpact in a report on Thursday, July 17th. They issued a "hold" rating and a $47.00 price target on the stock. Robert W. Baird cut their price objective on Genpact from $56.00 to $50.00 and set a "neutral" rating for the company in a report on Thursday, May 8th. Needham & Company LLC raised their target price on shares of Genpact from $50.00 to $53.00 and gave the company a "buy" rating in a research note on Friday, August 8th. Finally, JPMorgan Chase & Co. dropped their target price on shares of Genpact from $55.00 to $50.00 and set a "neutral" rating for the company in a research report on Wednesday, August 20th. Three research analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. According to data from MarketBeat, Genpact has an average rating of "Hold" and a consensus price target of $52.29.

About Genpact

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.